Randomized, dose-escalation study of the p38α MAPK inhibitor SCIO-469 in patients with myelodysplastic syndrome

L. Sokol; L. Cripe; H. Kantarjian; M. A. Sekeres; S. Parmar; P. Greenberg; S. L. Goldberg; V. Bhushan; J. Shammo; R. Hohl; A. Verma; G. Garcia-Manero; Y. P. Li; A. Lowe; J. Zhu; A. F. List

doi:10.1038/leu.2012.264

Randomized, dose-escalation study of the p38α MAPK inhibitor SCIO-469 in patients with myelodysplastic syndrome

L. Sokol, L. Cripe, H. Kantarjian, M. A. Sekeres, S. Parmar, P. Greenberg, S. L. Goldberg, V. Bhushan, J. Shammo, R. Hohl, A. Verma, G. Garcia-Manero, Y. P. Li, A. Lowe, J. Zhu, A. F. List

Hematology/Oncology

Research output: Contribution to journal › Letter

21 Scopus citations

Original language	English (US)
Pages (from-to)	977-980
Number of pages	4
Journal	Leukemia
Volume	27
Issue number	4
DOIs	https://doi.org/10.1038/leu.2012.264
State	Published - Apr 1 2013

ASJC Scopus subject areas

Hematology
Oncology
Cancer Research

Access to Document

10.1038/leu.2012.264

Cite this

Sokol, L., Cripe, L., Kantarjian, H., Sekeres, M. A., Parmar, S., Greenberg, P., Goldberg, S. L., Bhushan, V., Shammo, J., Hohl, R., Verma, A., Garcia-Manero, G., Li, Y. P., Lowe, A., Zhu, J., & List, A. F. (2013). Randomized, dose-escalation study of the p38α MAPK inhibitor SCIO-469 in patients with myelodysplastic syndrome. Leukemia, 27(4), 977-980. https://doi.org/10.1038/leu.2012.264

Randomized, dose-escalation study of the p38α MAPK inhibitor SCIO-469 in patients with myelodysplastic syndrome. / Sokol, L.; Cripe, L.; Kantarjian, H.; Sekeres, M. A.; Parmar, S.; Greenberg, P.; Goldberg, S. L.; Bhushan, V.; Shammo, J.; Hohl, R.; Verma, A.; Garcia-Manero, G.; Li, Y. P.; Lowe, A.; Zhu, J.; List, A. F.

In: Leukemia, Vol. 27, No. 4, 01.04.2013, p. 977-980.

Research output: Contribution to journal › Letter

Sokol, L, Cripe, L, Kantarjian, H, Sekeres, MA, Parmar, S, Greenberg, P, Goldberg, SL, Bhushan, V, Shammo, J, Hohl, R, Verma, A, Garcia-Manero, G, Li, YP, Lowe, A, Zhu, J & List, AF 2013, 'Randomized, dose-escalation study of the p38α MAPK inhibitor SCIO-469 in patients with myelodysplastic syndrome', Leukemia, vol. 27, no. 4, pp. 977-980. https://doi.org/10.1038/leu.2012.264

Sokol, L. ; Cripe, L. ; Kantarjian, H. ; Sekeres, M. A. ; Parmar, S. ; Greenberg, P. ; Goldberg, S. L. ; Bhushan, V. ; Shammo, J. ; Hohl, R. ; Verma, A. ; Garcia-Manero, G. ; Li, Y. P. ; Lowe, A. ; Zhu, J. ; List, A. F. / Randomized, dose-escalation study of the p38α MAPK inhibitor SCIO-469 in patients with myelodysplastic syndrome. In: Leukemia. 2013 ; Vol. 27, No. 4. pp. 977-980.

@article{07da50bb990b42c1902c004aeb9c8472,

title = "Randomized, dose-escalation study of the p38α MAPK inhibitor SCIO-469 in patients with myelodysplastic syndrome",

author = "L. Sokol and L. Cripe and H. Kantarjian and Sekeres, {M. A.} and S. Parmar and P. Greenberg and Goldberg, {S. L.} and V. Bhushan and J. Shammo and R. Hohl and A. Verma and G. Garcia-Manero and Li, {Y. P.} and A. Lowe and J. Zhu and List, {A. F.}",

year = "2013",

month = apr,

day = "1",

doi = "10.1038/leu.2012.264",

language = "English (US)",

volume = "27",

pages = "977--980",

journal = "Leukemia",

issn = "0887-6924",

publisher = "Nature Publishing Group",

number = "4",

}

TY - JOUR

T1 - Randomized, dose-escalation study of the p38α MAPK inhibitor SCIO-469 in patients with myelodysplastic syndrome

AU - Sokol, L.

AU - Cripe, L.

AU - Kantarjian, H.

AU - Sekeres, M. A.

AU - Parmar, S.

AU - Greenberg, P.

AU - Goldberg, S. L.

AU - Bhushan, V.

AU - Shammo, J.

AU - Hohl, R.

AU - Verma, A.

AU - Garcia-Manero, G.

AU - Li, Y. P.

AU - Lowe, A.

AU - Zhu, J.

AU - List, A. F.

PY - 2013/4/1

Y1 - 2013/4/1

UR - http://www.scopus.com/inward/record.url?scp=84876114118&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84876114118&partnerID=8YFLogxK

U2 - 10.1038/leu.2012.264

DO - 10.1038/leu.2012.264

M3 - Letter

C2 - 23032694

AN - SCOPUS:84876114118

VL - 27

SP - 977

EP - 980

JO - Leukemia

JF - Leukemia

SN - 0887-6924

IS - 4

ER -